hydrochlorothiazide has been researched along with olmesartan medoxomil in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 28 (35.00) | 29.6817 |
| 2010's | 48 (60.00) | 24.3611 |
| 2020's | 4 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Armirotti, A; Barone, M; Bertozzi, SM; Biagi, E; Brigidi, P; Candela, M; Cavalli, A; Falchi, F; Rampelli, S; Turroni, S | 1 |
| Chrysant, SG; Hinman, DJ; Wang, AC; Weber, MA | 1 |
| Ram, CV | 2 |
| Chrysant, GS; Chrysant, SG | 1 |
| Hinman, DJ; Manabe, S; Ogata, S; Sharyo, S | 1 |
| Arakawa, K | 1 |
| Lee, Y; Neutel, JM; Silfani, TN; Smith, DH; Weber, MA | 1 |
| Ambrosioni, E; Burnier, M; Hörl, W; Rabelink, AJ; Rump, LC | 1 |
| Chavanu, K; Merkel, J; Quan, A | 1 |
| Bolbrinker, J; Huber, M; Kreutz, R | 1 |
| Dubiel, R; Izzo, JL; Neutel, JM; Silfani, T; Walker, F | 1 |
| Greathouse, M | 1 |
| Lancellotti, P | 1 |
| Barrios, V; Boccanelli, A; Böhm, M; Ewald, S; Girerd, X; Heagerty, A; Krzesinski, JM; Lins, R; Rodicio, J; Stefenelli, T; Woittiez, A | 1 |
| Heagerty, A; Laeis, P; Mallion, JM | 1 |
| Dubiel, R; Kereiakes, DJ; Lipka, LJ; Neutel, JM; Punzi, HA; Xu, J | 1 |
| Barrios, V; Escobar, C | 1 |
| McCormack, PL; Scott, LJ | 1 |
| Amodeo, C; Brandão, AA; Feitosa, AD; Gomes, MA; Moriguchi, EH; Oigman, W; Précoma, DB; Ribeiro, AB; Ribeiro, JM; Saraiva, JF | 1 |
| Heagerty, AM; Mallion, JM | 1 |
| Chavanu, KJ; Chrysant, SG; Dubiel, R; Kereiakes, D; Oparil, S; Waverczak, W; Xu, J | 1 |
| Ali, SS; Arayne, MS; Sajid, S; Sultana, N | 1 |
| Punzi, HA | 2 |
| Haag, U; Miele, C; Volpe, M | 1 |
| Chavanu, KJ; Chrysant, SG; Xu, J | 1 |
| Barrios, V; Böhm, M; Calderon, A; Escobar, C | 1 |
| Bari, PD; Rote, AR | 1 |
| Chrysant, SG; Heyrman, R; Karki, S; Lee, J; Melino, M; Oparil, S | 1 |
| Chrysant, SG | 3 |
| Baszak, J; Fogari, R; Holm-Bentzen, M; Melani, L; Schumacher, K; Taddei, S | 1 |
| Dubiel, R; Kereiakes, DJ; Maa, JF; Shojaee, A | 1 |
| Fernandez, V; Heyrman, R; Lee, J; Melino, M; Oparil, S | 1 |
| Rump, LC; Sellin, L | 1 |
| Kereiakes, DJ; Neutel, J | 1 |
| Wilford Germino, F | 1 |
| Girerd, X; Rump, LC; Sellin, L; Stegbauer, J | 1 |
| Littlejohn, T; Neutel, JM; Qian, C; Ram, CV; Sachson, R; Shojaee, A; Stoakes, KA | 1 |
| Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A | 1 |
| Kereiakes, DJ; Maa, JF; Neutel, J; Shojaee, A; Stoakes, KA; Waverczak, WF | 1 |
| Kereiakes, DJ; Neutel, JM | 1 |
| Girerd, X; Rosenbaum, D | 1 |
| Chaudhari, AJ; Gorle, AP; Jain, PS; Patel, MK; Surana, SJ | 1 |
| Barrios, V; de la Sierra, A | 1 |
| Maa, JF; Punzi, H; Shojaee, A | 1 |
| Chavanu, KJ; Dubiel, R; Germino, FW; Maa, JF; Neutel, JM | 1 |
| Hsueh, WA; Maa, JF; Neutel, JM; Shojaee, A | 1 |
| Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn, T; Melino, M | 1 |
| Maa, JF; Nesbitt, SD; Shojaee, A; Weir, MR | 1 |
| Fernandez, V; Heyrman, R; Izzo, JL; Lee, J; Lewin, AJ; Melino, M | 1 |
| Agarwal, R; Weir, MR | 1 |
| Maa, JF; Shojaee, A; Weir, MR | 1 |
| Fernandez, V; Heyrman, R; Lee, J; Melino, M; Oparil, S; Roth, EM | 1 |
| Chae, SW; Choi, Y; Im, YJ; Jeon, JY; Jin, C; Jung, JA; Kim, MG; Kim, Y; Park, K | 1 |
| Hu, P; Jiang, J; Liu, DY; Wang, CG; Zhang, JY | 1 |
| Diab, SS; Merey, HA; Moustafa, AA; Ramadan, NK | 1 |
| Chrysant, SG; Fernandez, V; Izzo, JL; Kereiakes, DJ; Lee, J; Lewin, AJ; Melino, M; Oparil, S | 1 |
| Back, HM; Baek, IH; Chae, JW; Jung, SH; Kang, W; Kwon, KI; Lee, BY; Seo, JW; Song, BJ; Yun, HY | 1 |
| Baser, O; Frech-Tamas, F; Marrett, E; Xie, L | 1 |
| Brazier, JE; Guest, JF; Haag, U; Marques da Silva, P; Soro, M | 1 |
| Ammentorp, B; Laeis, P; Rump, LC; Scholze, J | 1 |
| Dinç, E; Ertekin, ZC | 1 |
| Chung, WB; Hong, TJ; Kim, BS; Kim, CJ; Oh, BH; Park, CG; Sohn, IS | 1 |
| Barger, B; Cushman, WC; Handley, A; Lloyd, E; Neutel, JM | 1 |
| Thomopoulos, C | 1 |
| van der Merwe, WM | 1 |
| Bakris, GL; Hisada, M; Juhasz, A; Kupfer, S; Lloyd, E; Oparil, S; Zhao, L | 1 |
| Abdelquader, MM; El Maghraby, GM; Essa, EA | 1 |
| Katakam, P; Katari, NK; Marisetti, VM; Siddhani, VK | 1 |
| Burnier, M; Redon, J; Volpe, M | 1 |
| Hong, JH; Hyun, D; Kim, GH; Kim, HL; Kim, W; Lim, S; Min, KW; Oh, J; Park, SD; Shin, J | 1 |
18 review(s) available for hydrochlorothiazide and olmesartan medoxomil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2004 |
[Development of combined drugs (ARB and diuretics)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Diuretics; Drug Combinations; Drug Design; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney Tubules, Proximal; Losartan; Olmesartan Medoxomil; Practice Guidelines as Topic; Renin-Angiotensin System; Sodium; Telmisartan; Tetrazoles | 2004 |
A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Factor Analysis, Statistical; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles | 2006 |
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Administration Schedule; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2006 |
[Medication of the month. Olmesartan medoxomil hydroclorothiazide (Olmetec Plus or Belsar Plus].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2007 |
Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2008 |
Olmesartan medoxomil: a review of its use in the management of hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diuretics; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2008 |
Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Practice Guidelines as Topic; Tetrazoles | 2009 |
Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 2010 |
Efficacy and safety of olmesartan medoxomil in patients with stage 1 hypertension: blood pressure lowering and goal achievement.
Topics: Angiotensin Receptor Antagonists; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2010 |
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2011 |
Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
Topics: Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2011 |
Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan | 2011 |
Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Design; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tetrazoles; Valine; Valsartan | 2011 |
Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2012 |
Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Calcium Channel Blockers; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Middle Aged; Multivariate Analysis; Olmesartan Medoxomil; Sex Factors; Tetrazoles | 2013 |
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Leukemia, Myeloid, Acute; Olmesartan Medoxomil | 2023 |
40 trial(s) available for hydrochlorothiazide and olmesartan medoxomil
| Article | Year |
|---|---|
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Diastole; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Imidazoles; Incidence; Male; Middle Aged; Olmesartan Medoxomil; Receptors, Angiotensin; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Treatment Outcome; United States | 2004 |
Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2006 |
Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2006 |
Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Cross-Over Studies; Diuretics; Drug Interactions; Humans; Hydrochlorothiazide; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2006 |
Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blocker.
Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2007 |
Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles | 2007 |
Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Double-Blind Method; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Nitrendipine; Olmesartan Medoxomil; Safety; Systole; Tetrazoles; Time Factors | 2007 |
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Diastole; Drug-Related Side Effects and Adverse Reactions; Female; Goals; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Systole; Tetrazoles; Treatment Outcome | 2007 |
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2008 |
Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Diuretics; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Practice Guidelines as Topic; Tetrazoles | 2009 |
Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2009 |
Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Practice Guidelines as Topic; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome | 2009 |
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Topics: Age Factors; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Middle Aged; Olmesartan Medoxomil; Placebo Effect; Racial Groups; Tetrazoles; Time Factors; Treatment Outcome; United States | 2010 |
Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Dizziness; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2010 |
Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, mult
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Combinations; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome | 2010 |
Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Algorithms; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2010 |
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Severity of Illness Index; Tetrazoles | 2010 |
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
Topics: Aged; Algorithms; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Placebos; Prospective Studies; Tetrazoles | 2010 |
Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2011 |
Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles; Treatment Outcome | 2011 |
Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.
Topics: Age Distribution; Aged; Ambulatory Care; Black People; Blood Pressure; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Olmesartan Medoxomil; Racial Groups; Sex Distribution; Tetrazoles | 2011 |
Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Euphoria; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Young Adult | 2011 |
Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2012 |
Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Treatment Outcome | 2012 |
Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Olmesartan Medoxomil; Tetrazoles | 2012 |
Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Renal Insufficiency, Chronic; Tetrazoles | 2012 |
Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
Topics: Adult; Aged; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
Topics: Adolescent; Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2013 |
Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Treatment Outcome; Young Adult | 2013 |
Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: a TRINITY subanalysis.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Olmesartan Medoxomil; Prevalence; Tetrazoles; Treatment Outcome | 2013 |
Pharmacokinetic properties and bioequivalence of olmesartan medoxomil/hydrochlorothiazide in healthy Korean male subjects.
Topics: Adult; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Humans; Hydrochlorothiazide; Imidazoles; Olmesartan Medoxomil; Tetrazoles; Therapeutic Equivalency | 2014 |
Pharmacokinetics and tolerability of olmesartan medoxomil plus hydrochlorothiazide combination in healthy Chinese subjects: drug-drug interaction, bioequivalence, and accumulation.
Topics: Adult; Cross-Over Studies; Drug Combinations; Drug Interactions; Female; Humans; Hydrochlorothiazide; Imidazoles; Male; Olmesartan Medoxomil; Tetrazoles; Therapeutic Equivalency | 2014 |
Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles; Treatment Outcome | 2014 |
Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Double-Blind Method; Female; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Least-Squares Analysis; Male; Middle Aged; Olmesartan Medoxomil; Tetrazoles | 2014 |
Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Chromatography, Liquid; Cross-Over Studies; Drug Combinations; Humans; Hydrochlorothiazide; Imidazoles; Male; Models, Biological; Nonlinear Dynamics; Olmesartan Medoxomil; Republic of Korea; Tablets; Tandem Mass Spectrometry; Tetrazoles; Therapeutic Equivalency; Young Adult | 2014 |
Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Quality of Life; Tetrazoles; Treatment Outcome | 2015 |
Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil | 2016 |
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Young Adult | 2016 |
Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Olmesartan Medoxomil; Oxadiazoles; Treatment Outcome | 2017 |
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.
Topics: Aged; Benzimidazoles; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
22 other study(ies) available for hydrochlorothiazide and olmesartan medoxomil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Searching for New Microbiome-Targeted Therapeutics through a Drug Repurposing Approach.
Topics: Drug Repositioning; Gastrointestinal Microbiome; Gene Expression Profiling; High-Throughput Screening Assays; Humans; Validation Studies as Topic | 2021 |
[Fast to the blood pressure goal. Lengthy dose adjustments harm compliance].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Controlled Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Middle Aged; Olmesartan Medoxomil; Patient Compliance; Placebos; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors | 2003 |
[From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
Topics: Antihypertensive Agents; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Placebos; Tetrazoles; Time Factors | 2003 |
Angiotensin receptor blockers and diuretics as combination therapy: clinical implications.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Diastole; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Imidazoles; Olmesartan Medoxomil; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Treatment Outcome | 2004 |
Renal effects of 26-week administration of olmesartan medoxomil/hydrochlorothiazide in rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Urea Nitrogen; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hydrochlorothiazide; Imidazoles; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Tetrazoles; Toxicity Tests | 2004 |
Based treatment algorithm for essencial hypertension with olmesartan medoxomil.
Topics: Adult; Aged; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Reference Values; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2008 |
Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Headache; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Meta-Analysis as Topic; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles; Time Factors; Treatment Outcome | 2009 |
Simultaneous determination of olmesartan medoxomil and irbesartan and hydrochlorothiazide in pharmaceutical formulations and human serum using high performance liquid chromatography.
Topics: Biphenyl Compounds; Blood Chemical Analysis; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Imidazoles; Irbesartan; Olmesartan Medoxomil; Pharmaceutical Preparations; Reproducibility of Results; Tetrazoles; Time Factors | 2008 |
Ratio spectra derivative and zero-crossing difference spectrophotometric determination of olmesartan medoxomil and hydrochlorothiazide in combined pharmaceutical dosage form.
Topics: Calibration; Drug Combinations; Hydrochlorothiazide; Imidazoles; Olmesartan Medoxomil; Spectrophotometry, Ultraviolet; Tablets; Tetrazoles | 2009 |
Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Stability; Hydrochlorothiazide; Imidazoles; Linear Models; Olmesartan Medoxomil; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tetrazoles | 2012 |
[Hypertension: improved therapy adherence after switch to a fixed drug combinations].
Topics: Amlodipine; Antihypertensive Agents; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Substitution; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Tetrazoles | 2012 |
Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Hispanic or Latino; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Tetrazoles | 2012 |
Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide.
Topics: Absorption; Amlodipine; Hydrochlorothiazide; Imidazoles; Olmesartan Medoxomil; Reproducibility of Results; Spectrophotometry; Tetrazoles; Water | 2014 |
A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Odds Ratio; Olmesartan Medoxomil; Retrospective Studies; Tetrazoles | 2014 |
Three-way analysis of the UPLC-PDA dataset for the multicomponent quantitation of hydrochlorothiazide and olmesartan medoxomil in tablets by parallel factor analysis and three-way partial least squares.
Topics: Chromatography, High Pressure Liquid; Databases, Factual; Factor Analysis, Statistical; Hydrochlorothiazide; Imaging, Three-Dimensional; Least-Squares Analysis; Olmesartan Medoxomil; Tablets | 2016 |
Long-term safety of different antihypertensive regimens: The risk of unfair comparisons.
Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Olmesartan Medoxomil; Oxadiazoles | 2018 |
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide.
Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles | 2018 |
Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination.
Topics: Antihypertensive Agents; Crystallization; Drug Combinations; Hydrochlorothiazide; Olmesartan Medoxomil; Solubility | 2018 |
Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Hydrochlorothiazide; Limit of Detection; Linear Models; Olmesartan Medoxomil; Reproducibility of Results; Research Design; Tablets | 2021 |
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Female; Heart Disease Risk Factors; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Republic of Korea; Risk Factors; Tetrazoles | 2023 |